MRI features in 17 patients with l2 hydroxyglutaric aciduria  by Fourati, Héla et al.
MH
I
a
b
c
a
A
R
R
A
A
K
l
L
M
S
1
s
P
b
c
a
1
c
f
i
c
[
c
b
m
a
W
R
h
2European Journal of Radiology Open 3 (2016) 245–250
Contents lists available at ScienceDirect
European  Journal  of  Radiology  Open
jou r n al hom epage: www.elsev ier .com/ locate /e j ro
RI  features  in  17  patients  with  l2  hydroxyglutaric  aciduria
éla  Fourati a,b,∗,  Emna  Ellouzeb,c, Mourad  Ahmadia, Dhouha  Chaarib, Fatma  Kamounb,c,
nes  Hsairib,c,  Chahnez  Trikib,c, Zeineb  Mnifb,c
Radiology Departement Hedi Chaker Hospital, EL Ain Road, 3002 3089 Sfax, Tunisia
Neuropediaty Reaserch Unit (UR12ES16), Faculty of Medecine at Sfax university Tunisia, Boulevard Majida Boulila 3089 Sfax Tunisia
Pediatric Neurology department Hedi Chaker Hospital, EL Ain Road, 3089 Sfax, Tunisia
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 21 July 2016
eceived in revised form 30 August 2016
ccepted 24 September 2016
a  b  s  t  r  a  c  t
l-2-Hydroxyglutaric  (l-2-HG)  aciduria  is a rare  inherited  metabolic  disease  usually  observed  in children.
Patients  present  a very  slowly  progressive  deterioration  with  cerebellar  ataxia,  mild or  severe  mental
retardation,  and  various  other clinical  signs  including  extrapyramidal  and  pyramidal  symptoms,  and
seizures  Goffette  et al. [1].  This  leukencephalopathy  was ﬁrst  described  in 1980  Duran  et  al.  [2]. Brainvailable online 27 September 2016
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RI
magnetic  resonance  imaging  (MRI)  demonstrates  nonspeciﬁc  subcortical  white  matter  (WM)  loss,  cere-
bellar  atrophy  and  changes  in  dentate  nuclei  and  putamen  Steenweg  et  al. [3]. The diagnosis  is  highlighted
by  increased  levels  of  l-2-HG  in  body  ﬂuids  such  as urine  and  cerebrospinal  ﬂuid.
The  purpose  of this  study  is  to retrospectively  describe  the  brain  MRI  features  in  l-2-HG  aciduria.
©  2016  Published  by Elsevier  Ltd.  This  is an  open  access  article  under the  CC  BY-NC-ND  licensepectroscopy
. Introduction
l-2-Hydroxyglutaric (l-2-HG) aciduria is a rare recessive auto-
omal inherited metabolic disease usually observed in children.
atients present a very slowly progressive deterioration with cere-
ellar ataxia, mild or severe mental retardation, and various other
linical signs including extrapyramidal and pyramidal symptoms,
nd seizures [1]. This leukencephalopathy was ﬁrst described in
980 [2]. To date, there are a little above one hundred documented
ases in medical literature [2–4]. Most are published in case-report
orm. Steenweg publishes the largest series in 2009 [5]. Neuro
maging ﬁndings generally show subcortical leukoencephalopathy,
erebellar atrophy and changes in dentate nuclei and putamen
3,6]. Increased levels of l-2-HG in body ﬂuids such as urine and
erebrospinal ﬂuid or mutational analysis highlight the diagnosis
y molecular biology.
The purpose of this study is to retrospectively describe the brain
agnetic resonance (MR) abnormalities in patients with l-2-HG
ciduria and to identify some features in our series.Abbreviations: l-2-HG, l-2-Hydroxyglutaric; MRI, Magnetic resonance imaging;
M,  white matter; WMA,  white matter abnormalities; GM,  Gray matter.
∗ Corresponding author at: Radiology department, Hedi Chaker Hospital, EL Ain
oad, Sfax 3002 3089, Tunisia.
E-mail addresses: fourati hela@yahoo.fr, fouratihela15@gmail.com (H. Fourati).
ttp://dx.doi.org/10.1016/j.ejro.2016.09.001
352-0477/© 2016 Published by Elsevier Ltd. This is an open access article under the CC B(http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case series
2.1. Patients and methods
During a three-year period (between March 1st, 2011, and
March 1st, 2014), 17 patients (age range: 3–28 years; median age,
11,6 years) (Table 1) with a clinical suspicion of (l-2-HG) aciduria
disease underwent brain MRI  examination, including, in ﬁve cases,
proton MR  spectroscopy.
Patients underwent MRI  within a 35,6-day period, (period range,
1-120 days; median period 30 days) after the outset of the ﬁrst
clinical abnormality. All patients were followed in the pediatric
neurology Department.
Meanwhile, the clinical suspicion was conﬁrmed by the
increased levels of l-2-HG in body ﬂuids and by molecular biology.
Brain MRI  examinations were performed with a 1.5-T MR  imag-
ing system with a head coil. All our patients underwent general
anaesthesia or mild sedation in order to perform MRI  examination.
The sedation was  necessary because of the mental retardation in
all the patients.
The protocol (Table 2) included sagittal T1 weighted images,
axial and coronal T2 weighted Fast Spin Echo (FSE) sequences in
all cases, T2 FLAIR (ﬂuid attenuated inversion recovery) weighted
images in almost half of the cases (47%) and diffusion-weighted
images (DWI) in only three cases (17,6%).
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1
Patient’s distribution by age group.
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Table 3
MR abnormalities reading gird.
WM*  Structures Lobes Yes/No; location
Frontal WM
Temporal WM
Parietal WM
Occipital WM
Predominantly involved lobe
Subdivison
Predominantly involved zone
Other structures
Corpus callosum
Extreme/External capsule
Internal capsule involved
Cerebellar WM
Cerebellar peduncles
Brainstem
WMA** Symmetry
WM Swelling
Predominant location of swollen WM
WM  rarefaction
Cysts
GM*** Structures Cerebral cortex
Thalamus
Globus pallidus
Caudate nucleus
Putamen
Dentate nucleus
Cerebellar cortex
Atrophy Cerebral atrophy
Cerebellar atrophy (vermis/hemispheres)
T
MMonovoxel spectroscopy was added in the protocol in ﬁve
atients (both long TE and short TE in three cases and only long
E in 2 patients).
A contrast agent was administered in one patient who  have an
ssociated cerebral heamatoma to determine yhe underlying cause.
he patients did not receive the same MR  protocol because the MR
mages were collected for three centers, but all the patients were
ll followed in the pediatric neurology departement in our hos-
ital, which is, specialized, inter alia, in metabolis diseases. Two
adiologists, 5 and 15 years of experience with pediatric MR image
nterpretation respectively, performed retrospectively the analy-
is of the available images. A consensus reading was  performed.
he radiologists were informed about the diagnosis but blinded to
linical condition.
This analysis was based on the collection of some items sys-
ematically for each patient according to a pre-established reading
ird (Table 3). The predominant location of the abnormalities was
recised.
For the location of the White matter abnormalities (WMA), the
eaders noted the involvement of the subcortical WM,  the periven-
ricular WM and the central WM.  WM swelling was  deﬁned as
ncreased volume leading to broadening of gyri; WM rarefaction
as deﬁned as T2-hyperintense WM areas with low signal inten-
ity on FLAIR images, but not as low as the signal intensity of
erebrospinal ﬂuid [3].
For the basal ganglia was noted the presence of an outer rim sign
eﬁned by a more proeminent signal intensity in the periphery.
. Results
White matter MR  abnormalities which are consisting of either
welling or rarefaction were present in the frontal and tempo-
al lobes of the brain in all cases (Fig. 1). Parietal and occipital
bnormalities were present in 94% and 88% respectively. WM
bnormalities were most severe in the frontal regions (82,3%)
Graph1).
Subcortical abnormalities were present in most cases, rep-
esenting the predominantly involved area (82,3%), followed by
entral WM (11,7%) and than periventricular WM (5,9%).
able 2
R protocol.
Sequence Plan Field Of View (cm) Echo Time (ms) Repe
SE T1 Sagittal 24 20 640 
FSE  T2 Axial 24 119,3 5400
FSE  T2 Coronal 24 119,3 5400
FLAIRa Axial 24 114 9502
Diffusion(b0, b1000) Axial 24 98,7 6000
T1  SPGRb 3D 24 4 9,2 
a Fluid Attenuated Inversion recovery.
b spoiled gradient.WM:  White matter; WMA**: White matter abnormalities; GM***: Gray matter.
Extreme and external capsules were affected in 9 patients
(52,9%). Internal capsule was  affected in only two  cases (Fig. 2).
Internal and external capsules were both spared in 41,2% of cases.
Corpus callosum and cerebellar WM were spared in all cases. Brain-
stem was  affected in only one patient (5,9%).
WM abnormalities were bilaterally symmetrical in all the
patients. These WM abnormalities were conﬂuent in 12 patients.
Affected WM swelling was  seen in 13 patients (76,5%), involving
more frequently frontal (76,5%) and temporal (64,7%) lobes. Occipi-
tal lobe was  spared in all cases. Among affected areas, predominant
swollen WM was seen in frontal lobe in 11 patients (84,6%) (Fig. 3).
Atrophy of cerebral WM was found in 47,1% of our patients.
Cerebellar vermis atrophy was found in 11,8%, and cerebellar hemi-
spheres in only one patient.
In 2 of 17 patients, there were cystic changes involving the
frontal lobe in one case and the dentate nucleus in the other. In one
case the readers noted a WM rarefaction involving the temporal
lobe (Fig. 4).
Cerebral cortex was involved in only one case (temporal lobe),
while none of our patients had cerebellar cortex abnormalities.The dentate nucleus was affected in all patients (Fig. 5). Other
nuclei were variably affected, the caudate nucleus in 6 patients
(35,3%), the putamen in 12 patients (70,6%), the globus pallidus in
tition Time (ms) Flip Angle Section thickness (mm) Acquisition time (s)
90◦ 5 163
 90◦ 5 81
 90◦ 5 81
 90◦ 5 190
 5 54
90◦ 1,4 144
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Fig. 1. Axial T2 FSE weighted images showing signal abnormalities: “swelling” affecting subcortical white matter (WM)  (a, b) in almost all cerebral areas, with a slight
parieto-temporal predominance. External capsula and both of the thalami (a) are also affected.
Fig. 2. Axial T1 SE weighted image (a), and coronal T2 FSE weighted images (b and c) showing extensive WM abnormalities, affecting outer and inner capsula with mesencephlic
abnormalities. An outer rim sign can also be noted for the putamen.
Fig. 3. Coronal T2 FSE weighted images showing WM abnormalities involving subcortical, central and periventricular areas with swollen WM appearance. An outer rim sign,
outer  and inner capsula involvements are also present.
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Fig. 4. Coronal T2 FSE weighted images (a and b) and sagittal T2 FLAIR weighted images (c and d), showing WM abnormalities with WM swelling in frontal lobes (a and b).
some  of signal abnormalities present a hyposignal in T2 FLAIR sequence (ﬁgures c and d: WM rarefaction).
Fig. 5. Axial T2 FSE weighted images showing the involvement of the dentate
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Table 4
Gray matter MR abnormalities.
clinical presentation with psychomotor delay, mild mental retarda-ucleus (a), the globus pallidus (b). An outer rim sign is observed (c).
0 patients (58,8%) and the thalamus in only 3 cases (17,6%). Three
ut of the 6 cases where caudate nucleus was involved presented
n outer rim sign in the T2-weighted images, as well as 7 from the
2 patients who had putaminal abnormalities.
Gray matter (GM) structures involvement was  summarized in
he table below (Table 4).
Monovoxel magnetic resonance spectroscopy (MRS) was per-
ormed in 5 patients. In one patient MRS  was normal. It has revealed
ecrease in NAA, and choline peaks (Fig. 6) in four cases and mul-
iplet 2,2 −2,7 in one case.
We tried, also, to determine what correlations exist between
he clinical presentation (severity of the clinical prentation and the
isease’s duration) and the MR  parameters in collaboration with
he neuro-paediatritians. The MRI  of patients belonging to the same
amily were compared in order to give some speciﬁcities.No statistical correlation can be established because of thr small
number of patients in each family, but we think that the severity
of MR  parameters is correlated to the severity of clinical presenta-
tion rather than to the disease duration. However, the white matter
atrophy can be correlated to the disease duration. Moreover, we
found no imaging particularity correlated to the family afﬁliation.
The Fig. 7 illustrate MR features in two patients belonging to the
same family. The ﬁrst patient is 17 years old, the disease duration
for him is 16 years, he had severe clinical presentation with psy-
chomotor delay, moderate mental retardation, tremors, epilepsia,
pyramidal syndrom, chorea and rigiditity, cerebellar syndrom. The
patient is 35 years old, the disease duration is 34 years, he had mildtion, epilepsia, pyramidal syndrom, cerebellar syndrom, no chorea
and rigiditity, no tremors
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Fig. 6. Monovoxel spectroscopy on frontal WM abnormalities shows decrease of
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Graph 1. Predominantly involved lobe in Wight matter MR abnormalities.
F
iAA and Choline peaks.
. Discussion
l-2-Hydroxyglutaric aciduria occurs in both sexes. Symptoms
sually appear in early childhood [1]. The diagnosis is supported by
ncreased levels of l-2-HG acid in urine, plasma, and cerebro-spinal
uid [5] or by genetic analysis.
A close correlation between the clinical disability and the extent
f pathologic changes on MRI  has been reported [7]. The combina-
ion of sub-cortical leukoencephalopathy sparing the deep white
atter and the corpus callosum together with atrophy of the cere-
ellar vermis and involvement of both dentate nuclei has been
onsidered pathognomonic for l-2-HG aciduria [3]. Our results con-
ur with the literature: the most affected areas are subcortical
rontal WM and all of our patients had abnormalities in dentate
uclei. The dentate nucleus and putamen are constantly affected
n many series, whereas, globus pallidus and caudate nucleus
ere variably affected. In our patients, we observed putaminal
nvolvement in 71% of cases. Thalamus and brain stem spar-
ng is a characteristic clue for differentiating l-2-HG aciduria
rom Canavan’s disease in patients with macrocephaly and diffuse
eukoencephalopathy [8,9]. One of our patients had a brainstem
bnormal signal and in three cases we reported thalami anomalies.
There are a few descriptions of histologic brain ﬁndings in L2-HG
ciduria. They reported WM abnormalities (spongiosis, demyeli-
ation and cystic degeneration) most pronounced in sub-cortical
egions [10].
ig. 7. The comparison of the two coronal T2 slices in patient a and b show that in « a » t
nvolvement, these features are more pronouced in « b ». We also note the ventricules’ enSome studies have been reported, in which the authors describe
malignant brain tumors of variable nature, during the course of the
disease [6,11–13].
None of our patients had a brain tumor.
Few data on proton MR  spectroscopic changes are available.
Decreased NAA and choline peaks, together with an increase in the
myo-inositol peak, were reported [13]. l-2-HG acid is also known
to generate three multiplets centered, respectively, at 1.91, 2.03,
and 2.43 ppm [1]. An unusual singlet at 2.5 ppm has been recently
described using the multivoxel PRESS technique in another patient
[1]. A multiplet at 2.10–2.50 ppm might be seen, and could be gen-
erated by elevated glutamate and glutamine or l-2-hydroxyglutaric
acid itself, which has a similar chemical structure to glutamate [14].
We observed using the mono-voxel STEAM technique in four of
our patient a deacrease in NAA and Choline peaks and a multiplet
2.20–2.70 in one patient. The validity of identiﬁcation of an unusual
peak on proton MR  has been documented in other metabolic dis-
eases. However, no speciﬁc peaks have yet been clearly described
for HG acid [15].
Our study had several limitations due to its small number of
patients. Another limitation may  be the retrospective nature of
our study and the small number of patients in whom we practiced
magnetic resonance spectroscopy.
In the future, further studies investigating MRS  ﬁndings may
determine its role in the diagnosis and possibly in the stating of the
severity of the disease.
In conclusion, MRI  in L2HGA permit to ﬁnd morphological
changes involving particular areas. This study shows consistent
results with the literature.
here is obvious white matter signal abormality (in fronto-temporal), basal ganglia
largement in b (not present in a) du to white matter atrophy.
2 al of R
c
d
C
A
S
F
U
R
[
[
[
[
[
diffusion-weighted MRI  in two  patients with l-2-hydroxyglutaric aciduria,
Pediatr. Radiol. 33 (December (12)) (2003) 872–886.
[15] R.N. Sener, l-2 Hydroxyglutaric aciduria: proton magnetic resonance50 H. Fourati et al. / European Journ
Further studies with larger populations are needed to help the
linical management of patients with inhereted neurometabolic
isorders.
ompeting interest
The authors declare that there is no competing interest.
cknowledgements
1. Service de Neurologie Pédiatrique, C.H.U Hédi Chaker de Sfax,
fax, Tunisia 2. Laboratoire de Génétique Moléculaire Humaine,
aculté de Médecine de Sfax, Université de Sfax, Sfax, Tunisia; 3.
R/08-08, département de biochimie, hopital Rabta, Tunis, Tunisie.
eferences
[1] S.M. Goffette, T.P. Duprez, M.-C.L. Nassogne, M.-F.A. Vincent, C. Jakobs, C.J.
Sindic, l-2-Hydroxyglutaric aciduria: clinical, genetic, and brain MRI
characteristics in two adult sisters, Eur. J. Neurol. 13 (5) (2006) 499–504.
[2] M.  Duran, J.P. Kamerling, H.D. Bakker, A.H. van Gennip, S.K. Wadman,
l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit.
Metab. Dis. 3 (4) (1980) 109–112.
[3] M.E. Steenweg, G.S. Salomons, Z. Yapici, G. Uziel, E. Scalais, D.I. Zafeiriou, et al.,
l-2-Hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56
patients 1, Radiology 251 (3) (2009) 856–865.
[4] A. Larnaout, F. Hentati, S. Belal, C. Ben Hamida, N. Kaabachi, M.  Ben Hamida,
Clinical and pathological study of three Tunisian siblings with
l-2-hydroxyglutaric aciduria, Acta Neuropathol. 88 (4) (1994) 367–370.
[5] P.G. Barth, G.F. Hoffmann, J. Jaeken, W.  Lehnert, F. Hanefeld, A.H. van Gennip,
et  al., l-2-Hydroxyglutaric acidemia: a novel inherited neurometabolic
disease, Ann. Neurol. 32 (July (1)) (1992) 66–71.adiology Open 3 (2016) 245–250
[6] F. London, Gliomatosis cerebri in l-2-hydroxyglutaric aciduria, Acta Neurol.
Belg. 115 (December (4)) (2015) 749–751.
[7] I. Moroni, L. D’Incerti, L. Farina, M. Rimoldi, G. Uziel, Clinical, biochemical and
neuroradiological ﬁndings in l-2-hydroxyglutaric aciduria, Neurol Sci. 21
(April (2)) (2000) 103–108.
[8] M.  Topc¸ u, G. Erdem, I. Saatc¸ i, G. Aktan, A. Sims¸ ek, Y. Renda, et al., Clinical and
magnetic resonance imaging features of l-2-hydroxyglutaric acidemia: report
of  three cases in comparison with Canavan disease, J. Child Neurol. 11
(September (5)) (1996) 373–377.
[9] D.I. Zafeiriou, W.J. Kleijer, G. Maroupoulos, A.L. Anastasiou, P.
Augoustidou-Savvopoulou, F. Papadopoulou, et al., Protracted course of
N-acetylaspartic aciduria in two  non-Jewish siblings: identical clinical and
magnetic resonance imaging ﬁndings, Brain Dev. 21 (April (3)) (1999)
205–208.
10] C. Barbot, I. Fineza, L. Diogo, M.  Maia, J. Melo, A. Guimarães, et al.,
l-2-Hydroxyglutaric aciduria: clinical, biochemical and magnetic resonance
imaging in six Portuguese pediatric patients, Brain Dev. 19 (July (4)) (1997)
268–273.
11] P.A. Ozis¸ ik, N. Akalan, S. Palaog˘lu, M.  Topc¸ u, Medulloblastoma in a child with
the metabolic disease l-2-hydroxyglutaric aciduria, Pediatr. Neurosurg. 37
(July (1)) (2002) 22–26.
12] Patay Zoltan, Brent A. Orr, Barry L. Shulkin, Scott N. Hwang, Yuan Ying,
Alberto Broniscer, Frederick A. Boop, David W.  Ellison, Successive distinct
high-grade gliomas in l-2-hydroxyglutaric aciduria, J. Inherit. Metab. Dis. 38
(March (2)) (2015) 273–277.
13] S. Kurul, H. Cakmakc¸ i, E. Dirik, Glutaric aciduria type 1: proton magnetic
resonance spectroscopy ﬁndings, Pediatr. Neurol. 31 (September (3)) (2004)
228–231.
14] K. Aydin, M.  Ozmen, B. Tatli, S. Sencer, Single-voxel MR spectroscopy andspectroscopy and diffusion magnetic resonance imaging ﬁndings, J. Comput.
Assist. Tomogr. 27 (January/ February (1)) (2003) 38–43.
